The risks associated with the use of aprotinin have been discussed and confirmed more than enough. Heart surgery and kidney failure have come to denote a phenomenon that has occurred, sadly, with too many patients undergoing surgical interventions. Doctors use Trasylol (aprotinin) to have control over blood loss during heart surgical procedures. However, research, new and not so new, has discovered that the use of Trasylol increases (considerably) the risk of kidney failure. Annually, heart surgery and kidney failure connect in many situations in consequence of aprotinin having been administered to patients during surgical treatment. If you have someone close who has been given this drug and then went through kidney failure, this is a clear Trasylol Class Action Lawsuit situation.

Apart from kidney failure, Trasylol is also highly likely to cause trouble with breathing or dyspnea, rapid heart pounding, unsettled stomach symptoms and queasiness, itchiness, irritation, soreness or swelling of the skin, unexpected or acute pain in the upper body area or legs, headaches, inflammation of the oral cavity or of the neck. Further risks associated with Trasylol ? which could also form a basis for a Trasylol Class Action Lawsuit, where they occur ? are an almost 50% higher probability of an acute myocardial infarction, an 100% increased risk of heart failure (failure of the heart to provide enough blood flow to satisfy the body's necessities), and an almost 190% bigger risk of experiencing a stroke. Add to this the fact that it happens on a yearly basis for more than 10,000 people who have experienced heart surgical procedures to require renal dialysis because they have been administered aprotinin during the operation.

Can heart surgery and kidney failure be separated? Of course they can ? and this is possible by using other drugs that control blood flow during heart surgery. In addition, such drugs are less expensive and they are scientifically proven to be a lot less likely to lead to kidney failure. Indeed, Trasylol kidney damage can be avoided ? simply by not using Trasylol. Studies have been conducted on thousands of patients and they easily reached such conclusion. As long as Trasylol kidney damage could have been avoided, but it has not been because you have been erroneously informed on the risks associated with the use of this drug, you have a right to Trasylol Class Action Lawsuit.

Do not let heart surgery and kidney failure occurrences off the hook. Reports and studies have been performed too many times for patients to undergo heart surgical procedures unsuspecting the risks of using Trasylol. In the case where this has occurred, however, file your Trasylol Class Action Lawsuit and obtain your compensation for the damage suffered. Heart surgery is supposed to improve one's health, not to lead to additional health problems or to death because such drug has been administered. Doctors should think about eliminating the uses of aprotinin ? or at most use it in the cases where the medical advantage of diminished bleeding is vital to the therapeutic supervision of the patient and where the advantages definitely prevail over possible threats or side effects. In the end, the issue concerns the complete elimination of a drug that has been proven too many times to cause kidney failure and even decease.